Synergistic effect of bortezomib and valproic acid treatment on the proliferation and apoptosis of acute myeloid leukemia and myelodysplastic syndrome cells-Reference-Cited by-同舟云学术

Synergistic effect of bortezomib and valproic acid treatment on the proliferation and apoptosis of acute myeloid leukemia and myelodysplastic syndrome cells

Published:2011-02-22 Issue:8 Volume:90 Page:917-931
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Wang Ai-Hua,Wei Lin,Chen Li,Zhao Shu-Qing,Wu Wei-Li,Shen Zhi-Xiang,Li Jun-Min

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-011-1175-6.pdf

Reference40 articles.

1. Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67:425–479

2. Muratani M, Tansey WP (2003) How the ubiquitin–proteasome system controls transcription. Nat Rev Mol Cell Biol 4:192–201

3. Anderson KC (2009) Proteasome inhibitors in multiple myeloma. Semin Oncol 36:S20–S26

4. Adams J, Palombella VJ, Elliott PJ (2000) Proteasome inhibition: a new strategy in cancer treatment. Invest New Drugs 18:109–121

5. Roccaro AM, Hideshima T, Richardson PG, Russo D, Ribatti D, Vacca A, Dammacco F, Anderson KC (2006) Bortezomib as an antitumor agent. Curr Pharm Biotechnol 7:441–448

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In the Pipeline: Emerging Therapy for Acute Myeloid Leukaemia;Pathogenesis and Treatment of Leukemia;2023

2. TP-DDI: A Two-Pathway Deep Neural Network for Drug–Drug Interaction Prediction;Interdisciplinary Sciences: Computational Life Sciences;2022-05-27

3. Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation;Pharmaceuticals;2021-05-02

4. Bortezomib suppresses self‐renewal and leukemogenesis of leukemia stem cell by NF‐ĸB‐dependent inhibition of CDK6 in MLL‐rearranged myeloid leukemia;Journal of Cellular and Molecular Medicine;2021-02-17

5. HDAC Inhibitors in Acute Myeloid Leukemia;Cancers;2019-11-14